Anti-IL13RA1 (Eblasakimab biosimilar) mAb (HDBS0434)
- SKU:
- HDBS0434
- Antibody Type:
- Biosimilar Reference Antibody
- Applications:
- IHC
- FC
- Drug Development
- Pharmacokinetics
- Disease Area:
- Cancer
- Size:
- 100 μg
- Target:
- IL13RA1
- Isotype:
- IgG4
- Host Species:
- Homo sapiens
- Reactivity:
- Human
Description
| Product Name: | Anti-IL13RA1 (Eblasakimab biosimilar) mAb |
| SKU: | HDBS0434 |
| Size: | 100 μg |
| Target: | IL13RA1 |
| Common Name: | ASLAN004, ASLAN-004, CSL-334 |
| Isotype: | IgG4 |
| Host Species: | Homo sapiens |
| Reactivity: | Human |
| Synonyms: | IL13R; IL13RA; CD213a1; CT19 |
| Applications: | ELISA Flow Cyt |
| Recommended Dilutions: | ELISA 1:5000-10000, Flow Cyt 1:100 |
| Conjugate: | Unconjugated |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
| Uniprot: | P78552 |
| Formulation & Reconstitution: | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Usage: | Research use only |
| Storage & Shipping: | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature. |
Related Products
Anti-CD93 (Biosimilar) mAb (HDBS0158)
€429
Anti-EPCAM (Oportuzumab biosimilar) mAb (HDBS0165)
€429
Anti-ANGPTL3 (Evinacumab biosimilar) mAb (HDBS0193)
€429
Anti-TNFa (Certolizumab biosimilar) mAb (HDBS0164)
€429
Anti-ADAM9 (Izeltabart biosimilar) mAb (HDBS0212)
€429